12 Health Care Stocks Moving In Monday's After-Market Session

Benzinga · 03/31 21:05
Gainers
- bioAffinity Technologies (NASDAQ:BIAF) stock rose 198.8% to $0.78 during Monday's after-market session. The company's market cap stands at $12.1 million. As per the press release, Q4 earnings came out today.
- Nutex Health (NASDAQ:NUTX) shares rose 51.02% to $70.3. The company's market cap stands at $382.2 million. As per the press release, Q4 earnings came out today.
- Compass Therapeutics (NASDAQ:CMPX) stock rose 18.42% to $2.25. The company's market cap stands at $309.5 million.
- Plus Therapeutics (NASDAQ:PSTV) stock moved upwards by 17.7% to $1.13. The market value of their outstanding shares is at $6.6 million. The company's, Q4 earnings came out 2 days ago.
- Bionano Genomics (NASDAQ:BNGO) stock moved upwards by 16.29% to $3.24. The market value of their outstanding shares is at $8.8 million. As per the press release, Q4 earnings came out today.
- Talphera (NASDAQ:TLPH) shares moved upwards by 10.48% to $0.55. The market value of their outstanding shares is at $9.3 million. The company's, Q4 earnings came out today.
Losers
- AquaBounty Techs (NASDAQ:AQB) stock fell 11.2% to $0.61 during Monday's after-market session. The market value of their outstanding shares is at $2.3 million.
- Evoke Pharma (NASDAQ:EVOK) shares declined by 8.9% to $2.51. The company's market cap stands at $3.7 million.
- Citius Oncology (NASDAQ:CTOR) shares decreased by 8.61% to $0.85. The market value of their outstanding shares is at $60.8 million.
- Enzo Biochem (NYSE:ENZ) stock declined by 7.83% to $0.34. The market value of their outstanding shares is at $17.8 million.
- Psyence Biomedical (NASDAQ:PBM) shares decreased by 6.67% to $0.56. The market value of their outstanding shares is at $2.5 million.
- Adverum Biotechnologies (NASDAQ:ADVM) stock declined by 6.64% to $4.08. The market value of their outstanding shares is at $84.8 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.